Background: Osteoarthritis (OA) of the lower limb affects millions of people worldwide, and results in pain and reduced function. We reviewed guidelines and Cochrane reviews for physical therapy interventions to manage the condition.
Introduction
Osteoarthritis (OA) is prevalent, disabling and has significant impact on health and social care resources, with~8.75 million people affected in the UK. 1, 2 The knee, hip and hand joints are predominantly involved, resulting in physical symptoms of pain, swelling and reduced function; and psychosocial symptoms of anxiety depression and reduced quality of life. 3 Primary care data suggest that 1 in 100 adults are newly diagnosed with the condition during the course of a year. 4 Diagnosis is most common in middle (over 45 years) and older age adults, but of interest is the increasing trend in incidence in people age 35-44 years. 4 The disease is generally managed within primary care, with more than one million annual GP consultations in the UK resulting from OA. 2 At present there is no cure for the disease, as such interventions are aimed at pain management with simple analgesia, and maximizing function and enhancing quality of life through non-pharmacological approaches. 5 Whilst some treatments are recommended, previous research suggests that management is frequently suboptimal, including under-utilization of clinically and cost-effective non-pharmacological interventions such as exercise and education, and inappropriate pharmacological management through inadequate prescription. [6] [7] [8] Given the current recommendations, most people who receive interventions for their OA are either managed by their GP (pharmacological) or physiotherapists for other physical therapy approaches, generally consisting of exercise with or without selfmanagement interventions; manual therapy, including joint mobilization and manipulation; transcutaneous electrical neuromuscular facilitation (TENS), an electrotherapeutic pain relieving device; and acupuncture. This paper reviews the evidence for physiotherapy interventions for lower limb OA recommended in guidelines relevant to practice in the UK.
Methods
Database searches were performed using MEDLINE, EMBASE, the Cochrane Library, National Institute for Health and Clinical Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN). Keywords search terms were applied to titles and abstracts, and included arthrit$; education$; electrother$; exercise; manual$; osteoarthr$; pain; physical; physio$; self-management; treatment$. Due to the abundance of literature in this area, papers were limited to meta-analyses or systematic reviews of clinical-effectiveness and published between 2010 and 2016. We also searched for guidelines and recommendations published by NICE, SIGN, Osteoarthritis Research Society International (OARSI) and the European League Against Rheumatism (EULAR). The original search was undertaken in May 2016 and reviewed in October 2016 to identify any contemporary publications that would inform the evidence.
Results
The search identified management guidelines from NICE, 9 OARSI 10 and EULAR. 11 American College of Rheumatology 12 and the Royal Australian College of General Practitioners 13 guidelines were also identified, but given the presence on National, European and OARSI documentation, the former were considered less relevant to UK practice. Table 1 identifies the recommendations for physiotherapy interventions included within the guidelines.
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All guidelines recommended the use of exercise and education/self-management as key interventions for OA. NICE recommended the use of manual therapy (manipulation and stretching) as an adjunct to exercise, particularly in people with hip OA; manual therapy was not included within the other two publications (OARSI stated this modality was not included due to insufficient evidence). TENS was recommended for use as an adjunct to core treatments by NICE, whilst OARSI were uncertain regarding recommendation due to low-quality evidence and no statistically different findings between TENS and sham treatments; EULAR did not include this modality. Acupuncture was categorically not recommended by NICE, yet OARSI expressed uncertainty regarding recommendation as clinical levels of significance were not demonstrated; this was not included in EULAR recommendations. OARSI included therapeutic ultrasound, although suggested an uncertain recommendation due to 
Optimizing therapeutic exercise
The findings of Juhl et al. 17 showed best effects were found for supervised exercise, carried out three times per week which comprised of at least 12 sessions. They included 48 trials and similar results were found for aerobic, resistance and performance exercise (SMD 0.67, 0.62 and 0.48, respectively, P = 0.733). Single type exercise programmes were found to be more efficacious than those that included a range of difference exercise types and the effect increased with number of sessions and more pain reduction occurred when exercise was performed at least three times per week. No impact of intensity or duration of the sessions was found. Regnaux et al. 18 included six studies (n = 656) that compared high-and low-intensity exercise programmes; five studies exclusively recruited people with knee OA (n = 620). Although they found the overall quality of evidence to be low, the evidence indicated reduced pain on a 20-point WOMAC pain scale for high-intensity exercise (SMD −0.84, 95% CI −1.63 to −0.04; 4% absolute reduction, 95% CI −8% to 0%; number needed to treat for an additional beneficial outcome (NNTB) 11, 95% CI 14-22) and improved physical function on the 68-point WOMAC disability subscale (SMD −2.65, 95% CI −5.29 to −0.01; 4% absolute reduction; NNTB 10, 95% CI 8-13) immediately at the end of the exercise programmes (from 8 to 24 weeks). However, none of these small improvements continued at long-term follow-up (up to 40 weeks after the end of the intervention). The authors were uncertain of the effect on quality of life, as only one study reported this outcome (0-200 scale; SMD 4.3, 95% CI −6.5 to 15.2; 2% absolute reduction; very low level of evidence).
Self-management education interventions
A Cochrane review by Kroon et al. 19 included 29 studies (n = 6753) comparing self-management education (SME) programmes to attention control, usual care or alternative interventions. Overall results suggested that at best programmes have small benefits, and adverse effects are unlikely. Analysis showed that at 12 months SME participation did not result in significant benefits compared to attention control. They found low-quality evidence from one study indicating that self-management skills were similar in active and control groups; the mean difference between groups was 0.4 points (95% CI −0.39 to 1.19). A further four low-quality studies indicated that SME programmes resulted in a statistically small but clinically non-meaningful reduction in pain: the SMD between groups was −0.26 (95% CI −0.44 to −0.09); number needed to treat for an additional beneficial outcome (NNTB) of 8 (95% CI 5-23). Low-quality evidence from a further study indicated the mean global OA score was 4.2 on a 0-10 scale in the control group, and with treatment symptoms reduced by a mean of 0.14 points (95% CI −0.54 to 0.26). Three further low-quality studies demonstrated no significant difference in function between groups (SMD −0.19, 95% CI −0.5 to 0.11); mean function was 1.29 points on a 0-3 scale in the control group; SME treatment produced a mean improvement of 0.04 points (95% CI −0.10 to 0.02). One low-quality study investigating quality of life showed no between-group difference (MD −0.01, 95% CI −0.03 to 0.01). Eleven moderate quality studies (n = 1706) demonstrated that when compared to usual care, SME interventions benefits may provide small, longterm benefits (<21 months) in pain and function, but no improvement in quality of life. Furthermore the authors questioned whether the observed improvements equated to clinical importance. Withdrawal rates throughout were similar for all interventions.
A further analysis by Brand et al. 20 comparing SME with or without exercise, identified 24 randomized controlled trials or cohort studies (n = 3163) that used the Arthritis Self-Efficacy Scale (ASES).
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The results from these studies demonstrated small to moderate effect sizes irrespective of whether the intervention combined SME with exercise. When considering the duration of interventions, Carnes 22 reported that self-management programmes that included a healthcare professional delivery, and were group based were more beneficial. The authors also reported that longer duration interventions (>8 weeks) did not equate to improved outcomes. Data also suggested that interventions which included a psychological component were consistently slightly more beneficial -there was insufficient information to determine which specific components were predominantly beneficial.
Manual therapy
A systematic review undertaken by French et al. 23 investigating the effects of manual therapy on pain and function identified four eligible RCTs (n = 280), three included participants with knee OA and the other studies hip OA. The heterogeneity of interventions precluded met-analysis -studies included high velocity manipulations, stretching and traction, massage and myofascial trigger point release. The authors determined a potentially high risk of bias in two of the included studies. One study compared manual therapy to no treatment control, another to a placebo intervention manual therapy and electrotherapy intervention. Two studies compared manual therapy to alternative pharmacological and exercise interventions. The evidence suggested that shortterm benefits on pain and function, particularly in patients with Knee OA (compared with no intervention) and hip OA (compared to exercise). Long-term effects (6 months) were measured in one study and whilst some clinical benefits were sustained, effects sizes had diminished. From the limited evidence available, the authors concluded that 'silver level of evidence' was available to support the use of manual therapy for hip OA, but the evidence for the intervention for knee OA was less convincing and based on low-quality studies. 
Therapeutic ultrasound
A Cochrane review 26 identified evidence for the use of therapeutic ultrasound (TUS) for people with knee OA, although no trials were available investigating the effectiveness in hip OA. Whilst the quality of evidence was poor, based on limited numbers, and with a diversity of dosage, meta-analysis suggested there was a beneficial effect on pain compared to control interventions; a SMD of −0.49 (95% CI −0.76 to −0.23), equating to a pain score difference of 1.2 cm on a 10-cm VAS between ultrasound and control. The numbers needed to treat was 6 (95% CI 5-12). For function, results suggested a trend towards effectiveness. Analysis suggested a SMD of −0.64 (95% CI −1.42 to 0.14, P value = 0.11); this corresponded to a difference in WOMAC disability scale function scores of 1.3 units (ranging from 0 to 10) favouring ultrasound therapy. Numbers needed to treat were not calculated given the statistically insignificant result. There were no reported concerns regarding safety of this intervention.
The authors concluded that TUS may have potential to improve pain and possibly function in people with knee OA, but the quality of evidence limits the certainty of true effect size and the meaningful clinical benefits of the intervention.
Discussion
Management guidelines for lower limb OA exclusively recommend exercise as the most effective intervention, resulting in clinically meaningful outcomes for pain and function. Self-management education interventions are also recommended. The recommendation of other common physiotherapy modalities is inconclusive. NICE 9 suggest that manual therapy techniques and TENS be considered in addition to exercise interventions, whilst OARSI 10 conclude that there is insufficient evidence available to determine the effectiveness of manual techniques, and that there is no conclusive evidence to support or refute the use of TENS. Acupuncture is conclusively not recommended by NICE, whilst OARSI suggest that the evidence is uncertain given the statistically significant findings of trials, but the lack of clinically meaningful outcomes reported. OARSI also concluded that the evidence for the use of TUS was uncertain, particularly because low-quality trials were reported; NICE did not include this intervention in their guidelines.
Therapeutic exercise
Areas of agreement Overall, the general consensus from the reviews examining the role of therapeutic exercise is that in the short term it is beneficial for pain and function in those with hip and knee OA. Of interest, Uthman et al. 14 concluded that as of 2002 there was enough accumulated evidence demonstrating the significant benefit of exercise over no exercise and a combination of strengthening exercise with exercise aimed at increasing flexibility and aerobic capacity seem to be the 'best' exercise option physiotherapists can offer patients. This is in line with the OARSI recommendations that state OA patients should be encouraged to undertake regular aerobic, muscle strengthening and range of movement exercises.
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Areas of controversy Current guidelines relevant to UK practice report there is limited evidence for the benefit of one exercise type over another and recommend both strengthening and aerobic exercise as 'core' treatment. Unfortunately such guidelines fall short of providing any type of prescription for this patient population regarding dose intensity, frequency and duration. The findings of Juhl et al. 17 stated that optimal exercise for those with OA is supervised exercise, carried out three times per week which comprises of at least 12 sessions. In contrast with the findings of Uthman et al. 14 they stated that single type exercise programmes were found to be more efficacious than those that included a range of difference exercise types. No impact of intensity or duration of the sessions was found. In terms of intensity Regnaux et al. 18 stated that people with knee OA who perform high-intensity exercise may experience slight improvements in knee pain and function compared with a low-intensity exercise programme. However, they were unable to determine as to whether high-intensity exercise improves quality of life or increases the number of people who experience adverse events; furthermore, these findings were predominately based on low-quality trials.
Growing points
The results of reviews on this topic, such as the network meta-analysis by Uthman et al.
14 may be to be useful for policy makers, service commissioners and care providers when they make choices between multiple alternatives for physiotherapist led OA management.
Areas timely for developing research
There is an obvious lack of long-term follow-up in the trials reported. Further research is required to evaluate methods of helping people with OA to maintain long-term exercise as poor adherence may limit long-term effectiveness. High quality randomized controlled trials with long-term follow-up that explicitly addresses adherence to exercise are needed. Jordan et al. 27 stated that a standard validated measure of exercise adherence would be welcomed and should be used consistently in future studies. The evidence to date also relies on results from interventions delivered by healthcare professionals. Given the growing numbers of people affected by OA, and the limited availability of healthcare resources, alternative providers of exercise (e.g. community based exercise professionals) should also be investigated to determine whether this is a safe, effective approach -a Cochrane review of this approach is currently being undertaken.
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Self-management education interventions
Areas of agreement Whilst effect sizes are conservative, there is general agreement that educating patients about their disease, dispelling myths around the causes, and developing appropriate skills to facilitate self-management are beneficial.
Areas of controversy
Recent guidelines support the principles of SME in clinical practice. 9 However, evidence from the recent Cochrane review is less convincing; reporting low to moderate quality evidence and a relatively small effect size.
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Growing points Investigating the most appropriate and effective components of self-management interventions is required, including overt documentation of techniques employed. Mapping against the behavioural change taxonomy may allow for better implementation into practice.
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Areas timely for developing research Further studies investigating the clinical and costeffectiveness of on-line self-management education are warranted.
Manual therapy
Areas of agreement There is very little evidence available to determine the effectiveness of manual therapy. Whilst it appears to be safe, current evidence does not justify its use as a single intervention in clinical practice.
Areas of controversy
Although there is limited low-quality evidence for the benefits of manual therapy for knee and hip OA, NICE recommend this intervention as an adjunct to core interventions of exercise and self-management education. 
Growing points

Acupuncture
Areas of agreement Acupuncture demonstrates a small benefit compared with sham acupuncture.
Areas of controversy NICE conclusively do not recommend the use of acupuncture for lower limb OA due to its lack of added benefit compared to the sham intervention. Inconsistencies in recommendations are likely due to the consideration of most appropriate comparator. Some experts in the field have questioned the decision to compare to sham findings, stating that decisions were 'based on a desire to avoid ethical problems in promoting therapies whose effects may derive largely from placebo'. 33 
Growing points
The reported similarity in benefits of acupuncture compared to the sham intervention raise the question of the impact of placebo effect. Authors are questioning whether we should use placebo for our advantage in treating OA. 34 Areas for further research Definitive high quality trials of acupuncture are required that consider the most appropriate intervention comparator and determine the level of clinically meaningful difference.
Therapeutic ultrasound
Areas of agreement At present there is no evidence to support the use of therapeutic ultrasound in hip OA, but there is limited evidence to suggest that there may be benefits in knee OA.
Areas of controversy NICE do not include any recommendation regarding therapeutic ultrasound within their guidelines, yet this is a standard intervention available to physiotherapists.
Growing points
An updated Cochrane review suggested TUS may be beneficial for people with knee OA. The authors report that in contract to their original review, four further studies were identified, although methodological quality of the studies was judged as poor. For pain outcomes, the benefits of ultrasound corresponded to a difference in pain scores of −1.2 cm on a 10-cm VAS (95% CI −1.9 to −0.6 cm); and functional scores of −1.3 units on a standardized WOMAC disability scale ranging from 0 to 10 (95% CI −3.0 to 0.3). A recent study not included within the Cochrane review suggested that TUS did not provide any additional benefit to exercise in improving pain and function. 35 Areas for further research High quality studies are required to provide definitive evidence of the clinical benefits of TUS for people with knee and hip OA.
Conclusion
Physiotherapy management for OA consists of a variety of interventions. Whilst there is strong evidence for the therapeutic benefits of exercise, there are fewer high quality studies demonstrating the benefits of other modalities. Given the growing numbers of people affected by OA and the limited availability of healthcare resources, there is a strong argument to suggest that practitioners focus on educating patients about the benefits of exercise, and facilitating continued exercise participation in people with OA.
